ABOUT US

We are a leading drug development company aiming at developing innovative biopharmaceuticals and medical diagnostics that require scientific and clinical development as well as providing clinically proven and quality assured biosimilars to the global market

Innogene Kalbiotech Pte Ltd is a wholly owned subsidiary of PT Kalbe Farma, South East Asia's biggest listed healthcare group with a market capital exceeding USD1.5 billion (FY 2006).
 

VISION

To become a leading global drug development and diagnostic company in providing innovative and effective healthcare solution to fulfill unmet patients' needs.

MISSION

To develop and market clinically proven novel biopharmaceutical products, innovative diagnostic devices and to provide quality assured and cost effective biosimilars.